Before any new therapy can be used, a thorough identification of its toxicity and safety is required. Therefore, drug toxicology and safety pharmacology are central to the chemical and pharmaceutical industries, and demand for 'pre-trained' employees is extremely high.
Hosted by the Institute of Cancer Therapeutics, the course addresses key aspects of preclinical drug evaluation through the study of drug discovery and development; safety pharmacology; mechanisms of drug-induced toxicities; regulatory affairs and bioanalytical sciences.
It will provide you with state-of-the-art training in the area of preclinical toxicology with an emphasis on the molecular and in vivo aspects of toxicological assessment.
It is designed for individuals with a first degree in a scientific disciple who want to specialise in new medicines development or undertake employment in the pharmaceutical industry.
International Student Requirements:
English language requirements: IELTS at 6.0 or the equivalent.